Six Chinese Biotechs Bag $403m In Fresh Financing Rounds

 
• By Dexter Jie Yan

In immuno-oncology and beyond, Chinese investors are setting their sights on new targets in the biopharma arena.

fund raising
Chinese biotechs raise new funds for immuno-oncology therapies, neurodegenerative drugs, and vaccines. • Source: Alamy

More from China

More from Focus On Asia